Dr. Ricardo Cubedo describes 3 research highlights from the ESMO 2019 Congress, including targeted therapy for ovarian cancer, immunotherapy for lung cancer, and more study data on targeted tumor-agnostic treatment. Read More >>
ASCO's toll-free patient information line: 571-483-1780 or 888-651-3038
The Cancer.Net Blog was named one of Healthline's Best Cancer Blogs of 2019.
Trusted, compassionate information for people with cancer and their families and caregivers, from the American Society of Clinical Oncology (ASCO), the voice of the world’s cancer physicians and oncology professionals.